Murad Talahma, MD
Neurocritical Care · Orlando, FLNPI 1043534449
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Olympus America Inc. at 37.5% of the total. Reporting peaked in 2020 at $96 and has fallen 80.4% since, to $19 in 2025. That places this record below the midpoint for neurocritical care clinicians in FL, where the typical reported total is $309.
Across 8 payments — averaging $31.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$96
- UCB, Inc.$44
- Portola Pharmaceuticals, LLC$33
- Averitas Pharma Inc.$26
- Ceribell, Inc.$19
- Coaptech, Inc.$19
- plus $17 from 1 others
What the payments were for
- Food & beverage$255100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 1 | $96 |
| UCB, Inc. | 1 | $44 |
| Portola Pharmaceuticals, LLC | 2 | $33 |
| Averitas Pharma Inc. | 1 | $26 |
| Ceribell, Inc. | 1 | $19 |
| Coaptech, Inc. | 1 | $19 |
| ZOLL Circulation Inc | 1 | $17 |
How this compares
$255 in reported general payments places this provider in the 40th percentile of 36 neurocritical care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in Orlando
- Bassel RaadOrlando$609
- Sima PatelOrlando$447
- Abhi PandhiMiami$16K
- Kristine O PhelanMiami$7K
- Michael CrimminsAventura$6K
- Fadar OtiteMiami$5K
- Mubashir PervezWeston$3K
- Katharina BuslGainesville$1K
- Ashley RogersJacksonville$1K
- Marc-Alain BabiPort St Lucie$812
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.